These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10462093)

  • 1. Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet.
    Schuh KJ; Johanson CE
    Drug Alcohol Depend; 1999 Aug; 56(1):55-60. PubMed ID: 10462093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.
    Harris DS; Mendelson JE; Lin ET; Upton RA; Jones RT
    Clin Pharmacokinet; 2004; 43(5):329-40. PubMed ID: 15080765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations.
    Nath RP; Upton RA; Everhart ET; Cheung P; Shwonek P; Jones RT; Mendelson JE
    J Clin Pharmacol; 1999 Jun; 39(6):619-23. PubMed ID: 10354966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial.
    Gunderson EW; Hjelmström P; Sumner M;
    Clin Ther; 2015 Oct; 37(10):2244-55. PubMed ID: 26412801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers.
    Jönsson M; Mundin G; Sumner M
    Eur J Pharm Sci; 2018 Sep; 122():125-133. PubMed ID: 29940217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.
    Chawarski MC; Moody DE; Pakes J; O'Connor PG; Schottenfeld RS
    J Subst Abuse Treat; 2005 Dec; 29(4):307-12. PubMed ID: 16311183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of sublingual buprenorphine.
    Mendelson J; Upton RA; Everhart ET; Jacob P; Jones RT
    J Clin Pharmacol; 1997 Jan; 37(1):31-7. PubMed ID: 9048270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder.
    Dong R; Wang H; Li D; Lang L; Gray F; Liu Y; Laffont CM; Young M; Jiang J; Liu Z; Learned SM
    Drugs R D; 2019 Sep; 19(3):255-265. PubMed ID: 31197606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.
    Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD
    J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.
    Comer SD; Collins ED; Fischman MW
    Psychopharmacology (Berl); 2001 Feb; 154(1):28-37. PubMed ID: 11292003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site.
    Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP
    Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine.
    Everhart ET; Cheung P; Shwonek P; Zabel K; Tisdale EC; Jacob P; Mendelson J; Jones RT
    Clin Chem; 1997 Dec; 43(12):2292-302. PubMed ID: 9439446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the combination tablet of buprenorphine and naloxone.
    Chiang CN; Hawks RL
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S39-47. PubMed ID: 12738349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy.
    Bastian JR; Chen H; Zhang H; Rothenberger S; Tarter R; English D; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Jan; 216(1):64.e1-64.e7. PubMed ID: 27687214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block.
    McAleer SD; Mills RJ; Polack T; Hussain T; Rolan PE; Gibbs AD; Mullins FG; Hussein Z
    Drug Alcohol Depend; 2003 Oct; 72(1):75-83. PubMed ID: 14563545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and physiologic/behavioral effects of buprenorphine administered sublingually and intravenously to neonatal foals.
    Grubb TL; Kurkowski D; Sellon DC; Seino KK; Coffey T; Davis JL
    J Vet Pharmacol Ther; 2019 Jan; 42(1):26-36. PubMed ID: 30242851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
    Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
    J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans.
    Greenwald MK; Schuh KJ; Hopper JA; Schuster CR; Johanson CE
    Psychopharmacology (Berl); 2002 Apr; 160(4):344-52. PubMed ID: 11919661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.